Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
Date:11/15/2012

armacokinetics and anti-tumor activity of VAL-083 in patients with histologically confirmed initial diagnosis of primary WHO Grade IV malignant glioma (GBM), now recurrent.  Patients with prior low-grade glioma or anaplastic glioma are eligible, if histologic assessment demonstrates transformation to GBM.  Patients with secondary brain tumors due to CNS metastases are also eligible for the study.

GBM patients must have been previously treated for GBM with surgery and/or radiation, if appropriate, and must have failed both Bevacizumab (Avastin®) and temozolomide (Temodar®), unless either or both are contra-indicated. 

Response to therapy and disease progression will be evaluated by MRI prior to each treatment cycle.  An initial phase of the study will involve dose escalation cohorts until a maximum tolerated dose (MTD) is established in the context of modern care.  Once the modernized dosing regimen has been established, additional patients will be enrolled at the MTD (or other selected optimum dosing regimen).

DelMar Pharma is conducting the study under the direction of Dr. Howard Burris at the Sarah Cannon Research Institute in Nashville, Tennessee with a second center in Sarasota, Florida. 

Please refer to clinicaltrials.gov identifier NCT01478178 for further details on this clinical trial.

About DelMar Pharma
Del Mar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.  VAL-083 benefits from extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment o
'/>"/>

SOURCE Del Mar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
2. Access Pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th
3. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
4. Cardioxyl Pharmaceuticals Raises $28 Million In Series B Financing Led By OrbiMed Advisors
5. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
6. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
7. Frost & Sullivan: Lack of Proper Price Regulation for Pharmaceuticals
8. Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November
9. Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
10. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
11. Jazz Pharmaceuticals Announces Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... second quarter and year-to-date 2014 financial results on Monday, ... financial markets. The earnings press release will be accessible ... www.anipharmaceuticals.com . Arthur S. Przybyl ... C. Arnold , Vice President and Chief Financial Officer, ...
(Date:7/28/2014)... CLARA, Calif. , July 28, 2014  ProteinSimple ... assay for the Simple Western. This new assay allows users ... For the first time, Simple Western users can analyze ... The Simple Western has changed protein analysis as ... hassles of Western blot protocols - no messy gels, ...
(Date:7/28/2014)... 2014 OmPrompt today announces ... help it meet the global demand for customer ... logistics. Albion joins Shackleton Ventures.      ... the past 18 months OmPrompt has underpinned accelerated ... team and its operations. The new funding will ...
Breaking Medicine Technology:ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2ProteinSimple Says "Never Run a Gel Again!" 2OmPrompt Funded for Customer Automation Management Market Expansion 2
... 30 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... National Cancer Institute had approved a proposal to,perform ... in,the NCI 60 cancer cell line panel., ... warning,signal in several different types of cancer. This ...
... Spherix Incorporated,(Nasdaq: SPEX ) announced today that it ... manufacturer of bulk pharmaceutical ingredients,to supply a portion of ... of the unique sugar as a treatment for Type ... Practice) production batches,of D- tagatose for the Spherix New ...
Cached Medicine Technology:Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 2Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 3Spherix D-tagatose to be Supplied by Inalco SpA 2
(Date:7/28/2014)... According to court documents, the conflict dates to November ... Group (TMG), met with Rafael H. Harel, principal owner ... a broad project outline, were agreed upon for the development ... and marketing. , Though Caller continued to express ... of the project, praise was not accompanied by payment. The ...
(Date:7/28/2014)... 2014 TherapySites, the leading ... announced today its affiliation with the Illinois Association ... relationship allows TherapySites to continue to extend their online ... promotional offers. , “There has been a fundamental shift ... With nearly 3 billion Internet users, it is so ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According to the ... is a comprehensive guide that will help people get rid ... readers all the necessary information about heartburn and acid reflux. ... truth about heartburn , and risk factors for reflux disease. ... will help people get rid of symptoms of reflux disease ...
(Date:7/28/2014)... New York, NY (PRWEB) July 28, 2014 ... completed the exit of its investment in Loftware, Inc., ... Partners of Boston. Shore Points was the lead investor ... which the Company has become the leading international provider ... applications. , “Loftware has been a great investment for ...
(Date:7/27/2014)... 28, 2014 Hyaluronic Acid can hold ... the key to the power of Hyaluronic Serums. , ... Heshelow, founder of Sublime Beauty®. "But like collagen, it ... as ours improves skin moisture-retention and radiance." , ... to a healthy and beautiful look. Key Ingredients in ...
Breaking Medicine News(10 mins):Health News:Calko Medical Center Loses Website Twice over Non-Payment, According to Court Documents 2Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2
... Parental Loss Support Group helps adults cope with feelings of grief after ... 2nd, 10:00-11:30am, at Hospice By The Bay, 17 East Sir Francis Drake ... ... Hospice By The Bay,s eight-week Parental Loss Support Group helps adults ...
... Inc., a leading online retailer of contact lenses in the United States ... dry winter eyes can be easily prevented. , ... Bellevue, WA (PRWEB) ... retailer of contact lenses in the United States wants to ...
... marijuana use may significantly increase a man,s risk of ... to a study by researchers at Fred Hutchinson Cancer ... 9 in the journal Cancer ., The researchers ... of diagnosis was associated with a 70 percent increased ...
... less likely to survive the disease than white women, and ... decades to narrow this racial difference. That is the conclusion ... issue of CANCER , a peer-reviewed journal of the ... black women are more likely to die from uterine cancers ...
... 2009 Introduced by Congressman LewisWASHINGTON, Feb. 8 ... to help blind persons receiving Social Security Disability ... Blind Persons Return to Work Act of 2009 ... persons from reentering the workforce and will facilitate ...
... in the blood that influences immune cell migration also ... the build-up and breakdown of bones in the body. ... may provide a new target for scientists developing therapies ... rheumatoid arthritis. , The study comes from ...
Cached Medicine News:Health News:Hospice By The Bay Grief Group Helps Adults Who've Lost a Parent 2Health News:Contact Lens Wearers Should Blink More Often During Winter - Tips from VisionDirect.com to Keep Eyes Moist During Dry Winter Months 2Health News:Contact Lens Wearers Should Blink More Often During Winter - Tips from VisionDirect.com to Keep Eyes Moist During Dry Winter Months 3Health News:Marijuana use linked to increased risk of testicular cancer 2Health News:Marijuana use linked to increased risk of testicular cancer 3Health News:Marijuana use linked to increased risk of testicular cancer 4Health News:Black women with uterine cancers more likely to die than white patients 2Health News:National Federation of the Blind Praises Bill to Create Work Incentives and Opportunity 2Health News:Scientists discover key factor in controlling the breakdown of bone 2Health News:Scientists discover key factor in controlling the breakdown of bone 3
Silicone Flat Hubless Drains...
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
... manipulation and removal in the ... wire allows the basket to ... torsion. The unique tipless design ... damage and perforation. Supplied sterile ...
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: